Medical devices, healthcare technology and the business of care
510(k) clearance · K251417

ReVISION 2

Argus Cognitive, Inc. · Decision date Sep 9, 2026

MEDTECHLEDGER EXPLANATIONK251417

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for ReVISION 2, submitted by Argus Cognitive, Inc. of Hanover, NH, under 510(k) K251417 with a decision date of September 9, 2026. The device is regulated under 21 CFR 892.2050 as a Class II Medical Image Management and Processing System, product code QIH, in the Radiology panel. SESE is a 510(k) clearance, not a premarket approval. The submission lists K201632 (TomTec-Arena TTA2) as primary predicate and K223322 (ReVISION 1.0) as secondary predicate.

ReVISION 2 is described as standalone, web-based software as a medical device that accepts DICOM data from compatible ultrasound systems and produces a 3D right ventricular surface model through an AI contouring module, with volumetric, strain and curvature outputs and a structured outcome report. Its stated indications cover quantification and reporting of right ventricular structure and function in adults over 21 with suspected disease; pediatric use is excluded. The summary states no clinical testing was performed and that equivalence rests on nonclinical and analytical validation. The source does not disclose performance results, and the public record shows no authorized predetermined change control plan.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 9, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K251417
Regulatory pathway
510(k) premarket notification
Product code
QIH
Decision code
SESE
Decision date
Sep 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated Radiological Image Processing Software.

Product code
QIH
FDA device class
2

FDA decision timeline

  1. K251417 received

    Application receipt date recorded by FDA.

  2. K251417 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QIH

Product / regulatory recordCompanyPathwayDecision dateSource
Clever OneK260372
Ewoosoft Co., Ltd.510(k) clearanceNov 4, 2026FDA
Peek Health, S.A.510(k) clearanceNov 4, 2026FDA
AVICENNA.AI510(k) clearanceOct 19, 2026FDA
UAB Ligence510(k) clearanceOct 7, 2026FDA
NeuroDRK262134
Deep Reasoning Ai, Inc.510(k) clearanceOct 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Argus Cognitive, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hanover, NH

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records